Share on StockTwits

BioMed Realty Trust (NYSE:BMR)’s share price reached a new 52-week high during trading on Wednesday , StockRatingsNetwork reports. The stock traded as high as $22.52 and last traded at $22.52, with a volume of 388,529 shares. The stock had previously closed at $22.45.

BMR has been the subject of a number of recent research reports. Analysts at Stifel Nicolaus reiterated a “buy” rating on shares of BioMed Realty Trust in a research note on Monday, August 11th. They now have a $24.00 price target on the stock, up previously from $23.00. Separately, analysts at Jefferies Group raised their price target on shares of BioMed Realty Trust from $23.00 to $25.00 in a research note on Tuesday, July 22nd. Finally, analysts at MLV & Co
initiated coverage on shares of BioMed Realty Trust in a research note on Friday, June 27th. They set a “hold” rating and a $23.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $23.29.

The stock has a 50-day moving average of $21.84 and a 200-day moving average of $21.1. The company has a market cap of $4.305 billion and a P/E ratio of 84.72.

BioMed Realty Trust (NYSE:BMR) last announced its earnings results on Tuesday, August 5th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.04. The company had revenue of $171.16 million for the quarter, compared to the consensus estimate of $160.80 million. During the same quarter in the previous year, the company posted $0.37 earnings per share. The company’s revenue for the quarter was up 7.2% on a year-over-year basis. Analysts expect that BioMed Realty Trust will post $1.53 EPS for the current fiscal year.

In other BioMed Realty Trust news, CEO Alan D. Gold unloaded 26,615 shares of BioMed Realty Trust stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $22.17, for a total value of $590,054.55. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

BioMed Realty Trust, Inc operates as a real estate investment trust (NYSE:BMR), and the general partner of BioMed Realty, L.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.